Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
2 June 2024
23:19 | User:Rithish Nimmagadda diffhist +14 Rithish Nimmagadda talk contribs (→Pages Authored/Co-authored/Collaborated) |
N 23:19 | Iptacopa diffhist +11,398 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{VSRN}} |genericName=iptacopa |aOrAn=a |drugClass=complement factor B inhibitor. |indicationType=treatment |indication=adults with paroxysmal nocturnal hemoglobinuria (PNH). |hasBlackBoxWarning=Yes |adverseReactions=Most common adverse reactions in adults with PNH (incidence ≥10%) were headache, nasopharyngitis, diarrhea, abdominal pain, bacterial infection, viral infection, nausea, and rash. |blackBoxWarningTitle=Serious Infecti...") |
03:28 | WINREVAIR diffhist +581 Kosar Doraghi talk contribs |
|
02:54 | (Upload log) [Kosar Doraghi (9×)] | |||
|
02:54 Kosar Doraghi talk contribs uploaded File:IMG 1235.jpeg | ||||
|
02:53 Kosar Doraghi talk contribs uploaded File:IMG 1234.jpeg | ||||
|
02:52 Kosar Doraghi talk contribs uploaded File:IMG 1231.jpeg | ||||
|
02:51 Kosar Doraghi talk contribs uploaded File:IMG 1232.jpeg | ||||
|
02:49 Kosar Doraghi talk contribs uploaded File:IMG 1230.jpeg | ||||
|
02:49 Kosar Doraghi talk contribs uploaded File:IMG 1227.jpeg | ||||
|
02:48 Kosar Doraghi talk contribs uploaded File:IMG 1236.jpeg | ||||
|
02:46 Kosar Doraghi talk contribs uploaded File:IMG 1237.jpeg | ||||
|
02:41 Kosar Doraghi talk contribs uploaded File:IMG 1226.jpeg |
1 June 2024
03:21 | Template:KDRG diffhist +15 Kosar Doraghi talk contribs |
N 03:20 | WINREVAIR diffhist +16,566 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=sotatercept-csrk |aOrAn=an |drugClass=activin signaling inhibitor |indicationType=treatment |indication=adults with pulmonary arterial hypertension (PAH, WHO Group 1) to increase exercise capacity, improve WHO functional class (FC) and reduce the risk of clinical worsening events |hasBlackBoxWarning=Yes |adverseReactions=headache, epistaxis, rash, telangiect...") |
27 May 2024
|
N 23:47 | Template:JR 2 changes history +44 [Jonathan Reyes (2×)] | |||
|
23:47 (cur | prev) −25 Jonathan Reyes talk contribs | ||||
N |
|
22:59 (cur | prev) +69 Jonathan Reyes talk contribs (Created page with "Jonathan Reyes, M.D.[jona3098reyes@gmail.com]") |
N 23:42 | Evinacumab-dgnb diffhist +627 Jonathan Reyes talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{JR}} |genericName=evinacumab-dgnb |aOrAn=an |drugClass=angiopoietin-like 3 (ANGPTL3) inhibitor |indicationType=treatment |indication=Evanicumab-dgnb is an angiopoietin-like 3 (ANGPTL3) inhibitor that is FDA approved for the treatment of an adjunct to other low-density lipoproteincholesterol (LDL-C) lowering therapies for the treatment of adult and pediatric patients, aged 5 years and older, with homozygous familial hypercholestero...") |